Cite
HARVARD Citation
Okuhara, S. et al. (n.d.). Serum levels of interleukin‐22 and hepatitis B core‐related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B. Hepatology research. 44 (10), pp. E172-E180. [Online].